Efficacy of 0.2 μg/day fluocinolone acetonide implant (ILUVIEN) in eyes with diabetic macular edema and prior vitrectomy [PDF]
Angelina Meireles+11 more
openalex +1 more source
Corrigendum to “The 0.19-mg Fluocinolone Acetonide Intravitreal Implant Reduces Treatment Burden in Diabetic Macular Edema” [Am J Ophthalmol 2023;248;16-23] [PDF]
Pauline T. Merrill+4 more
openalex +1 more source
Cost Advantage of Fluocinolone Acetonide Implant (ILUVIEN®) versus Ranibizumab in the Treatment of Chronic Diabetic Macular Oedema [PDF]
Fahd Quhill, Annette B. Beiderbeck
openalex +1 more source
Management of Anterior Chamber Dislocation of a Fluocinolone Acetonide Implant: A Case Report [PDF]
Clara Monferrer-Adsuara+4 more
openalex +1 more source
The USER Study: A Chart Review of Patients Receiving a 0.2 µg/day Fluocinolone Acetonide Implant for Diabetic Macular Edema [PDF]
Alexander M. Eaton+3 more
openalex +1 more source
This is a two-center, case series of three patients with postoperative refractory cystoid macular edema (CME) and disruption of the iris–lens diaphragm, submitted to scleral fixation of fluocinolone acetonide implant. All patients achieved successful CME
Rita Costa Basto+10 more
doaj +1 more source
Intravitreal Fluocinolone Acetonide Implant (ILUVIEN®) for the Treatment of Retinal Conditions. A Review of Clinical Studies. [PDF]
Mushtaq Y+5 more
europepmc +1 more source
Fluocinolone Acetonide Enhances Anterograde Mitochondria Trafficking and Promotes Neuroprotection against Paclitaxel-Induced Peripheral Neuropathy. [PDF]
Tiwari AP+3 more
europepmc +1 more source